Neuropace, Inc. Common Stock (NPCE) is a publicly traded Healthcare sector company. As of November 12, 2026, NPCE trades at $7.67 with a market cap of $429.74M and a P/E ratio of -19.06. NPCE moved -3.91% today. Year to date, NPCE is -24.19%; over the trailing twelve months it is -10.93%. Its 52-week range spans $7.56 to $19.60. Analyst consensus is strong buy with an average price target of $19.60. Rallies surfaces NPCE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NPCE insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $7.67 |
| Market Cap | $429.74M |
| P/E Ratio | -19.06 |
| EPS | $-0.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.60 |
| 52-Week Low | $7.56 |
| Volume | 95.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $99.99M |
| Net Income | $-21.46M |
| Gross Margin | 77.23% |
5 analysts cover NPCE: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.60.